Why the study?
Although inwardly rectifying potassium channels control neuronal excitability and contribute to neurological disease mechanisms, their functional expression across various neurological disorders needed classification to guide research and drug development.
Key points are not available for this paper at this time.
Design
Review
Does not support clinical use of Kir modulators; leaves open their therapeutic potential pending targeted trials.
Along the last decade, the central role of ion channels in neurological diseases has been carefully studying. Especially, inwardly-rectifying potassium (Kir) channels controlling the cell excitability by acting towards the hyperpolarization phase of neuronal action potential are vital in the neurological disease mechanism. Recent functional studies have shown that the Kir channels associating with various neurological disorders, primarily epilepsy cannot carry K+ ions into the cell due to dysfunction. Investigations into the role of Kir channels with 7 subfamilies in the mechanism of neurological disorders (epilepsy, multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, autism, etc.) have shown that the Kir channels functionally may change. After the key role of Kir channels in the pathophysiology is shown, novel drug studies targeting these channels have begun to be developed. Mutations in genes encoding ion channel protein dysfunction have also been included in this review. This is the review to our knowledge in neurological disorders showing the functional expression of Kir channels. Our review shows that Kir channels may play a role in pathophysiology associated with neurologic diseases. In review, the role of Kir channels in various common neurological diseases will be classified and a resource will be created for the researchers.
No takes yet. Share an insight, caveat, or question.
A 2019 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: